Background: Preeclampsia is a human pregnancyassociated syndrome associated with hypertension, proteinuria, and endothelial dysfunction. We tested whether increased reactive oxygen species (superoxide and peroxynitrite) production and decreased bioavailability of the endothelial nitric oxide (NO) synthase (eNOS) cofactor tetrahydrobiopterin (BH4) contributes to maternal endothelial dysfunction in rats with pregnancy-induced hypertension and several characteristics of preeclampsia.
P
reeclampsia (PE) is a pregnancy-specific hypertensive syndrome and is one of the leading causes of fetal and maternal morbidity and mortality. 1 Preeclampsia appears to be multifactorial in etiology and distinct forms of PE may exist clinically. 2 It has been postulated that placental PE may result from improper placentation of the fetus, whereas maternal PE may originate from the maternal vasculature. 3 Regardless of the cause, PE is characterized by uteroplacental hypoperfusion, endothelial dysfunction, and hypertension, yet the mechanisms are not well defined.
The endothelium-derived dilator nitric oxide (NO) plays a key role in vascular tone and has become a promising target of PE research. The NO production by endothelial NO synthase (eNOS) increases during pregnancy to potentiate uteroplacental perfusion. However, during PE serum nitrite/nitrate levels have been reported to be increased, unchanged, or decreased compared with normal pregnant values, thus reflecting the complexity of measuring whole body NO by-products. Several studies have reported increased eNOS expression but decreased endothelium-dependent relaxation in systemic blood vessels from women with PE. 4, 5 If eNOS protein levels are increased in the setting of endothelial dysfunction during PE, then increased reactive oxygen species (ROS) production may be decreasing NO bioavailability.
Recent evidence suggests that the vascular redox state during PE is shifted toward excessive pro-oxidant produc-tion and decreased antioxidant protection. 6 The major source of the increased production of superoxide in PE is most likely NADPH oxidase, which is upregulated in placentas of women with PE. 6, 7 Superoxide reacts with NO to form peroxynitrite, which is also increased in placentas and systemic blood vessels of women with PE. 4, 8 Reduced NO bioavailability may result not only from superoxide-mediated degradation of NO, but also by peroxynitrite-mediated degradation of tetrahydrobiopterin (BH4), a major cofactor for eNOS in the production of NO. 9 In the absence of BH4, eNOS becomes uncoupled and generates more superoxide than NO, which further contributes to endothelial dysfunction. Whether increased ROS production and eNOS uncoupling occurs in the systemic vasculature of women with PE is unknown.
We previously described a rat model in which pregnant rats are treated with deoxycorticosterone acetate (DOCA; weekly intraperitoneal injection) and 0.9% saline in the drinking water (PDS rats). 10 These volume-expanded animals demonstrate hypertension, proteinuria, decreased plasma nitrate/nitrite levels, lower pup survival, and decreased uterine weight compared with pregnant rats (P), which mimic the major clinical characteristics of PE. Although PE is a human-specific disorder, these rats represent an animal model of pregnancy-induced hypertension in which vascular pathogenetic mechanisms can be studied.
We assessed endothelium-dependent dilation in mesenteric arteries from PDS and P rats, as well as in nonpregnant rats (Con) and nonpregnant rats treated with DOCA/0.9% saline (DS). In addition, we measured NO production, eNOS, heat shock protein 90 (HSP90) protein expression, and ROS levels in aortas from Con, DS, P, and PDS rats. We tested the hypothesis that increased NADPH oxidase-derived superoxide and peroxynitrite decreases NO and BH4 bioavailability leading to uncoupled eNOS and endothelial dysfunction in the maternal vasculature of PDS rats.
Methods

Animals and Blood Pressure Measurements
Male and female Sprague-Dawley (Harlan, Indianapolis, IN) rats weighing 200 to 250 g were used in all experiments. Female PDS rats were treated as described previously. 10 Briefly, DS and PDS females received 12.5 mg of DOCA (intraperitoneal injection) and were given 0.9% saline to drink, followed by weekly intraperitoneal injections of DOCA (6.25 mg). Tail-cuff systolic blood pressures (BP) (IITC, Inc., Woodland Hills, CA) were measured before euthanization. Urinary protein excretion was measured as described previously. 10 The P and PDS rats were euthanized on days 18 to 20 of pregnancy and Con and DS rats were euthanized after the same amount of time. The number of malformed fetuses was noted and the uterus was weighed both with and without pups. All procedures were approved by the respective Institutional Animal Care and Use Committees.
Organ Chamber Experiments
All rats were anesthetized with isoflurane and euthanized by exsanguination. Small mesenteric arteries (ϳ200 m) were immediately excised and placed in cold physiologic salt solution (PSS). 11 Vascular reactivity of isolated endotheliumintact arterial rings (3 mm) was measured as described previously. 11 All experiments were performed in the presence of indomethacin (10 mol/L) to inhibit cyclooxygenase.
Some arterial rings were incubated with N -nitro-Larginine (LNNA; 10 mol/L, 20 min) to inhibit NOS activity, superoxide dismutase (SOD; 150 U/mL, 30 min) to scavenge superoxide, apocynin (APO; 100 mol/L, 60 min) to inhibit NADPH oxidase activity, ebselen (Eb; 5 mol/L, 20 min) plus uric acid (UA; 100 mol/L, 20 min) to scavenge peroxynitrite, or sepiapterin (SEPIA; 100 mol/L, 30 min) to increase BH4 levels. Concentrationforce curves were obtained in a half-log, cumulative fashion to acetylcholine (ACh; 1 nmol/L to 100 mol/L) and sodium nitroprusside (SNP; 100 pmol/L to 100 nmol/L) after contraction to an EC 70 concentration of phenylephrine (1 mol/L, 20 min).
Preparation of Aortic Homogenates
Endothelium-intact aortic rings (ϳ4 mm) were incubated in the absence and presence of SOD (150 U/mL, 20 min), APO (100 mol/L, 60 min), or SEPIA (100 mol/L, 20 min) in 37°C PSS. The rings were then homogenized and protein concentration determined as previously described.
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Nitric Oxide Production
An assay using the cell-permeable dye 4-amino-5-methylamino-2=,7=-difluorofluorescein diacetate (DAF-FM diacetate; Molecular Probes, Carlsbad, CA) was used to measure peak NO production as described previously.
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Immunoblotting
Western blot analyses were performed as described previously using primary antibodies for eNOS 1:2500 (BD Transduction Labs, Franklin Lakes, NJ), nitrotyrosine 1 g/mL (Calbiochem, San Diego, CA), and HSP90 1:1000 (BD Transduction Labs, Franklin Lakes). 11 Densitometry is expressed as the ratio of Western blot to Coomassie blue-stained 42 kD ␤-actin band on the polyvinylidene fluoride (PVDF) membrane.
Superoxide and Peroxynitrite Measurements
Superoxide and peroxynitrite were measured by lucigeninand luminol-derived chemiluminescence as described previously. 12 In brief, endothelium-intact aortic rings (ϳ4 mm) were incubated for 30 min in the absence and pres-ence of SOD (150 U/mL), Eb (5 mol/L) plus UA (100 mol/L), LNNA (10 mol/L), APO (100 mol/L), or SEPIA (100 mol/L) in PSS and then placed in scintillation vials containing PSS and either lucigenin (5 mol/L) or luminol (500 mol/L). Levels of superoxide and peroxynitrite are expressed as relative light units (RLU)/ milligram dry tissue weight/minute.
Statistical Analyses
Results are presented as mean Ϯ SEM. The Student t test was used to compare variables between groups. An analysis of variance was used for multiple comparisons followed by the Student-Newman-Keuls post hoc test when necessary. The significance level was .05.
Results
Hypertension, Proteinuria, and Intrauterine Growth Restriction (IUGR) in PDS Rats
Blood pressure, urinary protein levels, number of fetuses, and total litter weights are presented in Table 1 . The P rats demonstrated a significant decrease in BP during pregnancy; however, systolic BP of PDS rats increased significantly. Importantly, systolic BP in DS rats were not significantly different compared with Con rats. The P and PDS rats exhibited significantly elevated urinary protein levels compared with Con and DS rats, but urinary protein levels were markedly higher in PDS rats compared with P rats. The PDS rats had one to three malformed fetuses in each litter, whereas P rats had none. In addition, the total litter weight and mean number of fetuses per litter (including malformed fetuses) was decreased significantly in PDS rats compared with P rats.
Decreased Endothelium-Dependent Dilation in Blood Vessels from PDS Rats
Maximal relaxation responses to ACh were decreased significantly in mesenteric arteries from PDS rats compared with Con, DS, and P rats (maximal relaxation from phenylephrine-induced contraction: Con ϭ 94% Ϯ 1%, DS ϭ 98% Ϯ 2%, P ϭ 102% Ϯ 4%, and PDS ϭ 68% Ϯ 2%; P Ͻ .05; Fig. 1 ). The NOS inhibition with LNNA abolished relaxation responses to ACh in all groups (Fig. 1) .
Scavenging of superoxide with SOD ( Fig. 2A) and inhibition of NADPH oxidase with APO (Fig. 2B) normalized ACh-induced relaxation responses in mesenteric arteries from PDS rats but had no significant effect on relaxation responses in arteries from Con, DS, and P rats. In addition, scavenging of peroxynitrite with Eb and UA restored ACh-induced relaxation responses in mesenteric arteries from PDS rats to Con, DS, and P levels (Fig. 3A) . We also tested whether uncoupled eNOS due to BH4 depletion contributes to the decreased relaxation responses of arteries from PDS rats. The SEPIA, a BH4 precursor, restored relaxation responses in mesenteric arteries from PDS rats to P levels and had no effect on relaxation of arteries from Con, DS, and P rats (Fig. 3B) .
Maximal endothelium-independent relaxation responses to SNP were not different between mesenteric arteries from Con, DS, P, and PDS rats (data not shown). However, mesenteric arteries from PDS rats demonstrated a significantly decreased sensitivity to SNP after LNNA (EC 50 value: PDS ϭ Ϫ7.8 Ϯ 0.1 [anti-log ϭ 1.5 ϫ 10 Ϫ8 ] and P ϭ Ϫ8.3 Ϯ 0.1 
138 Ϯ 4* † 9.8 Ϯ 0.3* † 10 Ϯ 1 † 36 Ϯ 6 † Con ϭ not pregnant; DS ϭ not pregnant ϩ deoxycorticosterone acetate (DOCA)/saline; n ϭ number of rats; P ϭ pregnant; PDS ϭ pregnant ϩ DOCA/saline. Values are mean Ϯ SEM. * P Ͻ .05 v Con; † P Ͻ .05 v P. [anti-log ϭ 5.7 ϫ 10 Ϫ9 ], P Ͻ .05). The EC 50 values for Con and DS were Ϫ8.0 Ϯ 0.1 (anti-log ϭ 1.1 ϫ 10
FIG
Ϫ8
) and Ϫ8.1 Ϯ 0.1 (anti-log ϭ 6.3 ϫ 10 Ϫ9 ), respectively.
Decreased NO Production in Blood Vessels from PDS Rats
Peak aortic NO production in PDS rats was decreased 45%, but was increased 24% in P rats, compared to controls (LNNA-sensitive peak DAF-FM diacetate fluorescent counts: Con ϭ 160,828 Ϯ 2762, DS ϭ 158,875 Ϯ 6218, P ϭ 199,982 Ϯ 10,510, and PDS ϭ 88,781 Ϯ 8457, P and PDS, P Ͻ .05 v Con; Fig. 4 ). To verify that the restoration of relaxation responses in blood vessels from PDS rats by depleting ROS or increasing BH4 levels was due to increased NO bioavailability/production, we measured LNNA-sensitive DAF-FM diacetate fluorescence in P and PDS aortas after incubation with SOD, APO, and SEPIA. Superoxide dismutase, APO, and SEPIA all restored peak aortic NO production in PDS rats to P levels (Fig. 4) , yet had no effect on NO production in P aortas.
Increased eNOS and Nitrotyrosine Expression in Blood Vessels from PDS Rats
Because NO-dependent relaxation responses and NO production were decreased in systemic arteries from PDS rats, we measured eNOS protein levels. Aortic eNOS protein expression was increased significantly in PDS rats compared to P rats (P Ͻ .05 v P; Fig. 5 ). The findings of decreased endothelium-dependent relaxation responses and peak NO production despite increased eNOS protein expression suggest that eNOS activity may be uncoupled or increased levels of ROS may decrease NO bioavailability. Vascular nitrotyrosine levels, a marker of peroxynitrite activity, were increased in aortas from PDS rats compared with P rats. A drastic difference was observed at ϳ48 kD 
FIG. 2.
Scavenging or inhibition of superoxide-restored endothelium-dependent relaxation responses in mesenteric arteries from pregnant deoxycorticosterone acetate (DOCA)/0.9% saline-treated (PDS) rats to those of mesenteric arteries from nonpregnant controls (Con), nonpregnant DOCA/0.9% saline-treated (DS) rats, and pregnant (P) rats. (A) Superoxide dismutase (SOD, 150 U/mL) or (B) apocynin (APO, 100 mol/L) normalized acetylcholine-induced relaxation responses in mesenteric arteries of PDS rats. Results are expressed as mean Ϯ SEM and the number of rats are in parentheses. ‫ء‬P Ͻ .05 v Con or P.
and Fig. 5 demonstrates this increased nitrotyrosine level in aortas from PDS rats compared with P rats (P Ͻ .05 v P; Fig. 5 ). The identity and function of this protein is being examined. Decreases in HSP90 also lead to uncoupled eNOS and superoxide generation, therefore we measured HSP90 protein expression in aortas from P and PDS rats. There were no significant differences in HSP90 expression between the two groups (Fig. 5) .
Increased ROS Levels in Blood Vessels from PDS Rats
To confirm that ROS levels are increased in blood vessels from PDS rats, we measured superoxide and peroxynitrite levels using lucigenin-derived and luminol-derived chemiluminescence, respectively. Aortic segments from PDS rats demonstrated an almost twofold increase in superoxide levels compared with Con, DS, and P rats (P Ͻ .05 v Con; Fig. 6A ). Superoxide dismutase, APO, LNNA, or SEPIA normalized superoxide levels in PDS rats suggesting that NADPH oxidase and uncoupled eNOS were sources of superoxide production (Fig. 6A) . Aortic segments from PDS rats also demonstrated a twofold increase in peroxynitrite levels compared with Con, DS, and P rats (P Ͻ .05 v Con; Fig. 6B) . The P rats also demonstrated increased aortic peroxynitrite levels compared with Con (P Ͻ .05 v Con, Fig. 6B ). Incubation of aortas from PDS rats with Eb/UA, APO, or SEPIA normalized peroxynitrite levels (Fig. 6B) . LNNA significantly decreased luminolderived chemiluminescence in PDS rat aortas; however, the values were still significantly higher than Con but were similar to P rats (Fig. 6B) .
Discussion
It has been established that endothelial dysfunction contributes to pregnancy-induced hypertension and PE; however, the pathogenetic mechanisms are still relatively unknown. We report that the vasculature from volumeexpanded, pregnant rats exhibit increased superoxide and peroxynitrite levels and decreased NO production and endothelium-dependent relaxation responses despite increased eNOS protein expression. Endothelium-dependent relaxation and NO production were restored by scavenging ROS, inhibiting NADPH oxidase-mediated superoxide production, or by "re"-coupling eNOS in arteries from PDS rats.
Recent evidence suggests that several distinct etiologies of PE may exist. 2, 3 Placental PE is mediated by abnormal placentation and placental ischemia, which ultimately lead to maternal vascular dysfunction, whereas maternal PE results from placental ischemia or maternal vascular dysfunction. 3 To examine the mechanisms involved in the pathophysiology of this syndrome, several animal models of pregnancy-induced hypertension exist that resemble PE including rats subjected to NOS inhibition during pregnancy, 13 inbred hypertensive mice (BPH/5), 14 pregnant rats subjected to reduced uterine perfusion pressure (RUPP), 15 and pregnant rats treated with soluble fms-like tyrosine kinase 1 (sFlt1) or endoglin. 16, 17 Like the other models, our model using rats, volume expanded with DOCA   FIG. 4 . Decreased peak aortic nitric oxide production in pregnant deoxycorticosterone acetate (DOCA)/0.9% saline-treated (PDS) rats compared to nonpregnant controls (Con), nonpregnant DOCA/ 0.9% saline-treated (DS) rats, and pregnant (P) rats. Peak N -nitro-L-arginine-sensitive DAF-FM fluorescence was decreased in PDS aortas but reversed by superoxide dismutase (SOD, 150 U/mL), apocynin (APO, 100 mol/L), or sepiapterin (SEPIA, 100 mol/L). Results are expressed as mean Ϯ SEM (n Ͼ3 rats for each group). ‫ء‬P Ͻ .05 v Con; †P Ͻ .05 v PDS.
FIG. 5.
Increased aortic endothelial nitric oxide synthase (eNOS) protein and nitrotyrosine expression in pregnant deoxycorticosterone acetate (DOCA)/0.9% saline-treated (PDS) rats compared with pregnant (P) rats. (Top) Western blots showing expression of eNOS, a tyrosine-nitrosylated protein (molecular weight ϳ48 kD), and HSP90 in aortas from P and PDS rats along with the Coomassiestained 42 kD ␤-actin band on the PVDF membrane. (Bottom) Densitometry for ratio of eNOS, nitrotyrosine (NTYR; ϳ48 kD protein), and HSP90 expression to PVDF ␤-actin protein content. Results are expressed as mean Ϯ SEM (n Ͼ3 rats for each group). ‫ء‬P Ͻ .05 v P. and saline produces many, but not all, of the characteristics of PE including hypertension, proteinuria, and IUGR. 10 Furthermore, our nonpregnant rats treated with DOCA and 0.9% saline do not exhibit increases in systolic BP, suggesting that pregnancy alters the ability to handle the excessive volume. 10 Other studies have induced hypertension in female rats using DOCA and saline 18, 19 ; however, we used a dose of ϳ1.2 mg/d DOCA, which is 2 to 10 times less than in other studies and we do not perform an uninephrectomy. Thus, excessive volume expansion, in this case induced by pregnancy plus low-dose exogenous mineralocorticoids, may represent a clinical form of pregnancy-induced hypertension or maternal PE in which there is a defect in water and salt handling. 10, 20 It should be noted that BP decline during pregnancy has been reported to occur in women with primary aldosteronism as well in other forms of preexisting hypertension. The difference in BP in these patients and the current animal model may be explained by salt intake. Our rats received substantial amounts of exogenous salt through the drinking water; however, patients with hyperaldosteronism are on low salt intake. In addition, it is clear that in these patients the vasodilatory forces can counter their volume overload.
Maternal endothelial dysfunction occurs during pregnancy-induced hypertension and PE; however, the role of the maternal vasculature in the development of the elevated BP is still unknown. We report significantly increased NO production and slightly increased smooth muscle sensitivity to NO in arteries from P rats compared to nonpregnant controls, which explains in part why systolic BP decreased during pregnancy. In contrast, systemic arteries from PDS rats demonstrated reduced endotheliumdependent relaxation and NO production despite increased eNOS protein levels, and seemed to lose the pregnancyinduced increase in smooth muscle sensitivity to NO. These findings both support and conflict those found in the RUPP model of PE. Endothelium-dependent dilation and NO production are decreased in aortic segments from RUPP rats; however, mesenteric artery relaxation responses are not decreased. [21] [22] [23] It is possible that the reduction in uterine perfusion pressure, which is initiated at day 14 of gestation, is too late to affect all vascular beds. Time course studies in both of these models are needed to delineate the role of maternal endothelial dysfunction in the development of pregnancy-induced hypertension.
Pregnancy is associated with a generalized state of increased oxidative stress. 24 However, excessive pro-oxidant forces are evident in humans and animals with hypertension and PE. The NADPH oxidase-mediated superoxide and peroxynitrite production are increased in placentas of humans with PE; however, only one study reported increased nitrotyrosine immunostaining in systemic vessels obtained from women with PE. 4, 7, 25 Our results demonstrating increased superoxide, peroxynitrite, and nitrotyrosine levels in systemic arteries of PDS rats support and extend this finding. Furthermore, inhibition of NADPH oxidase or scavenging of superoxide or peroxynitrite all restored endothelium-dependent relaxation responses and NO production to P levels. We are currently testing whether APO, SOD, or EB/UA treatment decreases the severity of PE-like symptoms in PDS rats.
The eNOS cofactor BH4 promotes eNOS dimerization and activity. Whether BH4 depletion and uncoupled eNOS occurs in the maternal vasculature of humans with hypertensive pregnancy disorders has not been examined. In the present study we demonstrate that exogenous BH4 in the form of sepiapterin restored endothelium-dependent relaxation responses of mesenteric arteries from PDS rats, increased vascular NO production, and reduced superoxide and peroxynitrite production. Furthermore, NOS inhibition decreased superoxide and peroxynitrite production in systemic blood vessels from PDS rats but had no effect in vessels from P rats suggesting that uncoupled eNOS contributes to the endothelial dysfunction of PDS rats. Alterations in HSP90 also affect eNOS generation of NO versus superoxide and a recent study reported decreased HSP90 protein levels in umbilical endothelial cells from women with PE. 26 However, we did not observe any
FIG. 6.
Increased aortic superoxide and peroxynitrite levels in pregnant deoxycorticosterone acetate (DOCA)/0.9% saline-treated (PDS) rats compared with nonpregnant controls (Con), nonpregnant DOCA/0.9% saline-treated (DS) rats, and pregnant (P) rats.
(A) Lucigenin-derived and (B) luminol-derived chemiluminescence measurements of superoxide and peroxynitrite, respectively, were increased in aortas from PDS rats compared with Con or P rats but restored by apocynin (APO, 100 mol/L), N -nitro-L-arginine (LNNA, 10 mol/L), or sepiapterin (SEPIA, 100 mol/L). Superoxide dismutase (SOD, 150 U/mL) and ebselen (Eb, 5 mol/L) plus uric acid (UA, 100 mol/L) markedly decreased lucigenin-and luminolderived chemiluminescence, respectively. Results are expressed as mean Ϯ SEM (n Ͼ3 rats for each group). ‫ء‬P Ͻ .05 v Con; †P Ͻ .05 v PDS.
differences in HSP90 protein expression between aortas from P and PDS rats. Although we did not directly measure BH4 levels in systemic arteries from PDS and P rats, bioavailability of BH4 or eNOS responsiveness to BH4 may explain why BH4 supplementation restored endothelial function in arteries from PDS rats. Peroxynitrite is known to degrade BH4 and the increased production of peroxynitrite in vessels from PDS rats may promote eNOS uncoupling. 9 Reduced levels of ascorbic acid, known to stabilize BH4, have been reported in women with PE and been shown to increase myogenic tone in mesenteric arteries of pregnant rats. [27] [28] [29] Alternatively, a study by Kukor and colleagues 30 reported that although BH4 levels are not different between placentas from P and PE women, placental eNOS from women with PE is "resistant" to activation by physiologic levels of exogenous BH4 but normalized after supraphysiologic concentrations of exogenous BH4. Taken together, these findings suggest that exogenous BH4 may be beneficial in women with pregnancy-induced hypertension and maternal PE.
In conclusion, increased production of superoxide by NADPH oxidase and peroxynitrite, along with uncoupled eNOS, contribute to endothelial dysfunction in the vasculature of volume-expanded, pregnant rats. Recent clinical trials with antioxidants in heterogeneous populations have been disappointing thus far; however, ROS scavenging or BH4 supplementation of women with pregnancy-induced hypertensive disorders may decrease the severity of the disease.
